Unique ALS ‘Exome-Sequencing’ Project Is Focus of New Grant

MDA has awarded a $400,000 grant to National Institutes of Health (NIH) Laboratory of Neurogenetics researchers to perform exome sequencing on samples taken from 1,000 people with sporadic amyotrophic lateral sclerosis (ALS). The project will be led by neurologist Bryan Traynor, head of the Neuromuscular Diseases Research Group at the NIH in Bethesda, Md.

ALS Community Tells FDA ‘We Have No Time To Waste’; Urges Changes in Trial Design and Review Process

Because of the relentless effects of ALS, a diverse group of ALS voices — patients, families, organizations and the community — came together to speak about their experiences with ALS and to urge the FDA to work with them to overcome some of the obstacles faced in ALS research, clinical trials and standards of care.

ALS TDI Investigating Immunomodulator CTLA4-FC in Mice

A growing body of evidence suggests that malfunction of the immune system is at least part of the ALS disease process. Now scientists are testing whether mouse CTLA4-FC effectively blocks CD86